Sunshine Biopharma
Stock Forecast, Prediction & Price Target
Sunshine Biopharma Financial Estimates
Sunshine Biopharma Revenue Estimates
Sunshine Biopharma EBITDA Estimates
Sunshine Biopharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $228.42K N/A | $4.34M 1802.41% | $24.09M 454.41% | Avg: $100M Low: $100M High: $100M avg. 315.06% | |||
Net Income
% change YoY
| $-12.76M N/A | $-26.74M -109.50% | $-4.50M 83.15% | Avg: $145.99K Low: $145.99K High: $145.99K avg. 103.23% | |||
EBITDA
% change YoY
| $-2.42M N/A | $-8.13M -234.93% | $-3.82M 52.96% | Avg: $-83.84M Low: $-83.84M High: $-83.84M avg. -2092.45% | |||
EPS
% change YoY
| -$81.45 N/A | -$176.17 -116.29% | -$370.41 -110.25% | Avg: $0.6 Low: $0.6 High: $0.6 avg. 100.16% | |||
Operating Expenses
% change YoY
| $2.55M N/A | $10.37M 306.57% | $13.12M 26.55% | Avg: $958.96M Low: $958.96M High: $958.96M avg. 7206.72% | |||
FAQ
What is Sunshine Biopharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 103.23% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is 145.99K, average is 145.99K and high is 145.99K.
What is Sunshine Biopharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 315.06% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $100M, average is $100M and high is $100M.
What is Sunshine Biopharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 100.16% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is $0.6, average is $0.6 and high is $0.6.